EDESA BIOTECH, INC. Payments to Acquire Interest in Joint Venture
EDESA BIOTECH, INC. (EDSA) reported Payments to Acquire Interest in Joint Venture of $0 for the 12-month period ending 2017-09-30, per its 10-K filed 2017-12-01.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInterestInJointVenture · last filed 2017-12-01
- EDESA BIOTECH, INC. payments to acquire interest in joint venture for the quarter ending 2017-09-30 was $0.00.
- EDESA BIOTECH, INC. payments to acquire interest in joint venture for the quarter ending 2016-09-30 was $0.00.
- EDESA BIOTECH, INC. payments to acquire interest in joint venture for the quarter ending 2015-09-30 was $0.00.
- EDESA BIOTECH, INC. payments to acquire interest in joint venture for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- EDESA BIOTECH, INC. payments to acquire interest in joint venture for fiscal 2016 was $66.69K.
- EDESA BIOTECH, INC. payments to acquire interest in joint venture for fiscal 2015 was $0.00.
- EDESA BIOTECH, INC. payments to acquire interest in joint venture for fiscal 2014 was $0.00.
| Period end | Payments to Acquire Interest in Joint Venture 1 month | Payments to Acquire Interest in Joint Venture 3 month | Payments to Acquire Interest in Joint Venture 9 month | Payments to Acquire Interest in Joint Venture 12 month |
|---|---|---|---|---|
| 2017-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-01 | $0.00 10-K · filed 2017-12-01 | ||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-09 | |||
| 2016-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-01 | $66.69K 10-K · filed 2017-12-01 | ||
| 2016-06-30 | $66.69K 10-Q · filed 2017-08-09 | |||
| 2015-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-01 | $0.00 10-K · filed 2017-12-01 | ||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-09 | |||
| 2014-09-30 | $0.00 10-K · filed 2016-12-14 | |||
| 2014-08-31 | $0.00 10-K · filed 2016-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |